The elevation of FGF23 may occur before any other echocardiographic marker of cardiac dysfunction and mirror the raised cardiovascular risks which allows the classification of asymptomatic CKD patients who are at risk of symptomatic and advanced HF and cardiac death. This evidence concerns the gene FGF23 and chronic kidney disease.